(19)
(11) EP 4 739 337 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24740105.2

(22) Date of filing: 04.07.2024
(51) International Patent Classification (IPC): 
A61K 38/46(2006.01)
A61P 1/18(2006.01)
C12N 9/94(2006.01)
 A61P 1/14(2006.01)
A61K 38/54(2006.01)
A61K 47/69(2017.01)
(52) Cooperative Patent Classification (CPC):
A61P 1/14; A61P 1/18; C12N 9/94; A61K 38/54; C12Y 302/01001; C12Y 301/01003; A61K 47/6923; A61K 47/6929; A61K 47/61
(86) International application number:
PCT/EP2024/068860
(87) International publication number:
WO 2025/008458 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 EP 23183881

(71) Applicants:
  • Perseo Pharma AG
    4132 Muttenz (CH)
  • Société des Produits Nestlé S.A.
    1800 Vevey (CH)

(72) Inventors:
  • LAPRÉVOTTE, Emilie
    68220 Hegenheim (FR)
  • BRIAND, Manon
    5408 Ennetbaden (CH)
  • DUDAL, Yves Victor René
    4103 Bottmingen (CH)
  • SPECIOSO, Gabriele
    4303 Kaiseraugst (CH)
  • SHAHGALDIAN, Patrick
    68220 Hegenheim (FR)
  • WATSON, John Ashleigh
    8880 Walenstadt (CH)

(74) Representative: Latscha Schöllhorn Partner AG 
Grellingerstrasse 60
4052 Basel
4052 Basel (CH)

   


(54) FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS COMPRISING PANCREATIC ENZYMES